Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002962 (
angina
)
21,142
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent investigations of SMI occurring during daily life have advanced our understanding of the pathophysiology of myocardial ischemia. These contributions have directed our attention away from "chest pain" alone and physical exertion as the central provoking factor toward transient myocardial ischemia and its broader triggers and consequences. Transient myocardial ischemic episodes, the majority of which are silent, are found in a subset of patients with any clinical manifestations of CAD (eg, stable
angina
, unstable angina, myocardial infarction, and sudden death), as well as in those patients with CAD who are and have been totally asymptomatic. These episodes are an independent predictor of increased risk for future cardiac events. Most medical therapy and revascularization therapies have the potential to prevent or relieve these silent episodes; however, we do not yet know which method is superior in reducing SMI episodes or preventing future cardiac events. Furthermore, the benefit of reducing SMI versus the cost and potential morbidity of these chosen therapies is not known. At least three trials are now underway to examine some of these concerns (Table 2). Focus on pain relief alone does not appear to be an adequate approach to alter outcome in patients with CAD and may prove insufficient to control SMI. Until these issues are resolved, we believe a conservative approach to the management of patients with CAD is warranted. Documentation of ischemia (painful or painless) is essential. Three general principles should be kept in mind. First, the presence of detectable ischemia is of central importance. This information should be used in the overall risk assessment of the patient. Second, the level of concern or
aggressiveness
of treatment should be based on the risk associated with the ischemic abnormalities documented (Table 3). The exercise stress test is the most useful to begin this process. The detection of ischemic-type ST-segment depression, either silent or painful, at a low workload (eg, less than or equal to 120 beats per minute or less than or equal to 6.5 metabolic equivalents [METS]) implies high risk for adverse outcome. Likewise, these ST-segment changes occurring in leads that reflect multiple coronary artery distribution, of greater than 2 mm in magnitude and persisting for greater than 6 minutes, are all markers for high risk. Thallium redistribution defects occurring at low work loads, in multiple areas, associated with increased lung uptake and enlargement of the cardiac pool all imply high risk.(ABSTRACT TRUNCATED AT 400 WORDS)
...
PMID:Treatment strategies for daily life silent myocardial ischemia: a correlation with potential pathogenic mechanisms. 135 7
Although survival after coronary artery bypass grafting (CABG) is the most serious outcome information, the quality of life in living patients is largely determined by the freedom from ischemic events. The return of
angina
, acute myocardial infarct and sudden death were studied in a large (n = 5880) population of patients undergoing CABG between 1971 and 1987. The freedom from
angina pectoris
was 95%, 83% and 63% at 1, 5 and 10 years, respectively, after surgery. Early return of
angina
was related to both procedure incremental risk factors (incomplete revascularization and non-use of the internal mammary (thoracic) artery (IMA) as a conduit) and patient incremental risk factors (
aggressiveness
of the atherosclerotic process and severity of preCABG symptoms). Late
angina
return was related to patient risk factors including coexisting factors (hyperlipidemia and hypertension), preCABG symptom severity and gender (female). The freedom from an acute fatal or non-fatal postCABG myocardial infarct was 99%, 96% and 85% at 1, 5 and 10 years after surgery. The incremental risk factors for early infarction were related to incomplete revascularization, but late infarction was related to lipid levels, coexisting diseases (diabetes, positive family history) and non-use of IMA to LAD. The freedom from sudden death was 99.8%, 99% and 97% at 1, 5 and 10 years, respectively, after surgery. The incremental risk factors were dominated by the severity of the left ventricular dysfunction. The freedom from any ischemic event (any of the previous three) was 93%, 79% and 54% at 1, 5 and 10 years, respectively, after surgery. The incremental risk factors included all those cited above for the specific components. Patient-specific predictions validate the influences of these risk factors. They demonstrate that unlike the profound influence of the use of the IMA on survival, there is little benefit of the use of the IMA on return of ischemic events over and above the effect of revascularization per se. The study demonstrates that most patients will experience return of ischemic symptoms within a period of 15-20 years after surgery, but that this is most likely to be return of
angina
and rarely sudden death.
...
PMID:The return of clinically evident ischemia after coronary artery bypass grafting. 168 34
Epidemiological research identifies risk factors for coronary heart disease (CHD) to enable interventions to reduce the incidence of the disease. The twenty-year decline in cardiovascular-related deaths, however, cannot be explained solely by any pronounced changes in the classic risk factors (serum cholesterol, blood pressure and cigarette smoking) or related behaviors. Accordingly, it is apparent that there is much unexplained variance in the pathophysiology of CHD and that various behaviors are not associated with the classic risk factors in a simplistic fashion. Since acute and severe stress can affect thresholds for precipitation of cardiac events, the question of causality of long-term negative emotions has been repeatedly addressed; there is, however, no solid evidence that facets of neuroticism are related to documented acute coronary events while on the other hand, there is considerable evidence that emotionally maladjusted individuals have many complaints, including chest pain that is frequently labeled
angina
in spite of the absence of documented CHD. With regard to patterns of behavior in identifying risk factor status in CHD most attention has been focused on the Type A behavior pattern (hard-driving, job involvement, speed of activity, competitiveness,
aggressiveness
and mental and physical alertness). While this type of behavior has been related to clinical CHD independent of classic risk factors in some studies, the vast majority of epidemiological research has failed to replicate the association between the global Type A behavior pattern and any manifestation of CHD. Some attributes of the Type A behavior pattern, in particular, hostility, however, may be related to CHD even if the global pattern is not significantly associated.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Exercise hypertension: behavior and the dynamic action of risk factors. 358 6
The type A behavior pattern is characterized by excessive competitive drive, a sense of time urgency, enhanced
aggressiveness
, hostility and a persistent desire for recognition. Type A behaviour is widely recognized as a risk factor in coronary heart disease. This study investigated whether type As and Bs differ in their experience of pain and pain coping efforts. A group of type A (n = 35) and a group of type B (n = 19) cardiac disease patients served as subjects. All subjects underwent diagnostic treadmill testing and were compared on a variety of pain measures. There were no differences between type As and Bs in age, sex, presence of state or trait anxiety or severity of cardiac disease. Type A patients, however, were much more likely than type Bs to be classified on the New York Heart Association (NYHA) functional
angina
scale as having more severe pain and functional limitation. Type As were also less likely to use pain coping strategies to deal with their pain. Those who assess pain and functional impairment in cardiac patients using the NYHA scale should be aware that type A personality characteristics may affect their assessments. Type A patients who tend to make little use of pain coping strategies may benefit from systematic training in pain control methods. Additional research is needed to examine whether type A-B differences in pain and pain coping strategies may affect risks of coronary morbidity and mortality.
...
PMID:Angina pectoris in type A and type B cardiac patients. 379 16
Coronary heart disease is a major source of morbidity and mortality in women. Despite the importance of this health problem, women in general have not received the same degree of
aggressiveness
in diagnosis and treatment as men have received. Contributing to underdiagnosis and undertreatment in women include the results of the Framingham study, which showed that women with
angina
have better prognoses than men, and the results of multicenter percutaneous transluminal coronary angioplasty and coronary artery bypass grafting trials, which showed that women have higher morbidity and mortality rates in the periprocedure periods. These higher morbidity and mortality rates can largely be explained by the older ages of women when they have symptomatic coronary heart disease and the attendant higher incidence of comorbid diseases in an elderly population. Because of the cardiovascular protective effects of estrogen, the incidence of disease of the epicardial coronary arteries in the absence of significant risk factors in premenopausal women is very low despite the fairly high incidence of chest pain syndromes. Some of these women may have endothelial dysfunction, some small vessel disease, and some may have the visceral pain syndrome. When coronary heart disease does present in middle-aged women, it tends to be less severe than in middle-aged men. The recognized limitations of stress perfusion imaging in single vessel disease, as well as resolution limitations in small hearts and limitations due to soft tissue attenuation artifacts, all must be considered when imaging women. Applications of nuclear techniques to some of the unique aspects of chest pain in women such as small vessel disease or endothelial dysfunction represent as yet unmet challenges.
...
PMID:Sex specific issues relating to nuclear cardiology. 942 Aug 9